Sector consensus Merck KGaA

Equities

Market Closed - Xetra Other stock markets 20:47:23 12/12/2025 GMT			5-day change	1st Jan Change
118.40 ^EUR	-0.38%		-0.84%	-15.37%

12-11	Merck KGaA's SpringWorks Gets UK Clearance for Plexiform Neurofibromas Therapy	MT
12-11	UK's MHRA approves mirdametinib to treat plexiform neurofibromas	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
MERCK KGAA			€143.56	+20.54%	16
KYOWA KIRIN CO., LTD.			JP¥2,588.89	+2.43%	9
HALOZYME THERAPEUTICS, INC.			US$76.13	+22.98%	8
SK BIOPHARMACEUTICALS CO., LTD.			₩145,785.71	+7.43%	14
YUHAN CORPORATION			₩148,388.89	+27.92%	18
INDIVIOR PLC			US$37.86	+5.78%	7
BETTA PHARMACEUTICALS CO., LTD.			CN¥63.79	+32.56%	2
SUPERNUS PHARMACEUTICALS, INC.			US$60.5	+30.08%	6
SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.	-	-	-	-	-
OSCOTEC INC.	-		₩67,000	+11.85%	2
KISSEI PHARMACEUTICAL CO., LTD.			JP¥5,025	+9.6%	4
CHANGCHUN BCHT BIOTECHNOLOGY CO.			CN¥28	+42.06%	2
HK INNO.N CORPORATION			₩65,416.67	+25.56%	12
Average			36,217.92	+19.90%	8
Weighted average by Cap.			20,386.22	+18.72%	13